Liposomal delivery is plausible and supported by limited human research, but the word liposomal does not verify encapsulation, stability, absorption or clinical superiority
FDA concluded that based on the available evidence, that the supply of semaglutide meets or exceeds current demand, and that, based on our best judgment looking at the available information with its limitations, supply will meet or exceed projected demand. FDA acknowledges in the Declaratory Order that: [E]ven when a shortage is considered resolved, patients and prescribers may still see intermittent localized supply disruptions as products move through the supply chain from the manufacturer and distributors to local pharmacies
Treatment in other anatomical regions may be considered at the discretion of a qualified provider based on clinical judgment
From a technical standpoint, the long-term uptrend in LLY shares remains intact, and the breakout above the historical high resistance adds further conviction to the bullish setup
Cochrane Database of Systematic Reviews 2023
Antacids containing calcium carbonate or magnesium hydroxide can provide rapid symptom relief for breakthrough episodes